Recent Finacing
Recent Raise
Freya Biosciences is a transatlantic biotech developing vaginal microbial immunotherapies using a DYSCOVER multi-omics platform to identify engrafting Lactobacillus strains and immune biomarkers; lead candidate FB301 targets IVF outcomes.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
